Publikationen von Hannelore Ehrenreich

Weishaupt, J. H.; Bartels, C.; Pölking, E.; Dietrich, J.; Rohde, G.; Poeggeler, B.; Mertens, N.; Sperling, S.; Bohn, M.; Hüther, G. et al.; Schneider, A.; Bach, A.; Sirén, A.-L.; Hardeland, R.; Bähr, M.; Nave, K.-A.; Ehrenreich, H.: Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. Journal of Pineal Research 41 (4), S. 313 - 323 (2006)

Byts, N.; Samoylenko, A.; Woldt, H.; Ehrenreich, H.; Sirén, A.-L.: Cell type specific signalling by hematopoietic growth factors in neural cells. Neurochemical Research 31 (10), S. 1219 - 1230 (2006)

Brettschneider, J.; Widl, K.; Ehrenreich, H.; Riepe, M.; Tumani, H.: Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases. Neuroscience Letters 404 (3), S. 347 - 351 (2006)

Krampe, H.; Wagner, T.; Stawicki, S.; Bartels, C.; Aust, C.; Kroener-Herwig, B.; Kuefner, H.; Ehrenreich, H.: Personality disorder and chronicity of addiction as independent outcome predictors in alcoholism treatment. Psychiatric Services 57 (5), S. 708 - 712 (2006)

Hasselblatt, M.; Ehrenreich, H.; Sirén, A.-L.: The brain erythropoietin system and its potential for therapeutic exploitation in brain disease. Journal of Neurosurgical Anesthesiology 18 (2), S. 132 - 138 (2006)

Sirén, A.-L.; Radyushkin, K.; Boretius, S.; Kämmer, D.; Riechers, C.-C.; Natt, O.; Sargin, D.; Watanabe, T.; Sperling, S.; Michaelis, T. et al.; Price, J.; Meyer, B.; Frahm, J.; Ehrenreich, H.: Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin. Brain 129, S. 480 - 489 (2006)

Hasselblatt, M.; Krampe, H.; Jacobs, S.; Sindram, H.; Armstrong, V. W.; Hecker, M.; Ehrenreich, H.: Arginine challenge unravels persistent disturbances of urea cycle and gluconeogenesis in abstinent alcoholics. Alcohol and Alcoholism 41 (4), S. 372 - 378 (2006)

Krampe, H.; Stawicki, S.; Wagner, T.; Bartels, C.; Aust, C.; Rüther, E.; Poser, W.; Ehrenreich, H.: Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: Impact of alcohol deterrents on outcome. Alcoholism-Clinical and Experimental Research 30 (1), S. 86 - 95 (2006)

Knabe, W.; Sirén, A.-L.; Ehrenreich, H.; Kuhn, H.-J.: Expression patterns of erythropoietin and its receptor in the developing spinal cord and dorsal root ganglia. Anatomy and Embryology 210, S. 209 - 219 (2005)

Unzicker, C.; Erberich, H.; Moldrich, G.; Woldt, H.; Bulla, J.; Mechoulam, R.; Ehrenreich, H.; Sirén, A.-L.: Hippocampal cannabinoid-1 receptor upregulation upon endothelin-B receptor deficiency: A neuroprotective substitution effect ? Neurochemical Research 30 (10), S. 1305 - 1309 (2005)

Hültner, L.; Ehrenreich, H.: Mast cells and endothelin-1: a life-saving biological liaison? Trends in Immunology 26 (5), S. 235 - 238 (2005)

Heyer, A.; Hasselblatt, M.; von Ahsen, N.; Häfner, H.; Sirén, A.-L.; Ehrenreich, H.: In vitro gender differences in neuronal survival on hypoxia and in 17 beta-estradiol-mediated neuroprotection. Journal of Cerebral Blood Flow and Metabolism 25 (4), S. 427 - 430 (2005)

Diem, R.; Sättler, M. B.; Merkler, D.; Demmer, I.; Maier, K.; Stadelmann, C.; Ehrenreich, H.; Bähr, M.: Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. Brain 128, S. 375 - 385 (2005)

Ehrenreich, H.; Hasselblatt, M.; Knerlich, F.; von Ahsen, N.; Jacob, S.; Sperling, S.; Woldt, H.; Vehmeyer, K.; Nave, K.-A.; Sirén, A.-L.: A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain. Proceedings of the National Academy of Sciences of the United States of America 102 (3), S. 862 - 867 (2005)

Ehrenreich, H.; Aust, C.; Krampe, H.; Jahn, H.; Jacob, S.; Herrmann, M.; Sirén, A.-L.: Erythropoietin: Novel approaches to neuroprotection in human brain disease. Metabolic Brain Disease 19 (3-4), S. 195 - 206 (2004)

Jahn, H.; Doring, W. K. H.; Krampe, H.; Sieg, S.; Werner, C.; Poser, W.; Brunner, E.; Ehrenreich, H.: Preserved vasopressin response to osmostimulation despite decreased basal vasopressin levels in long-term abstinent alcoholics. Alcoholism-Clinical and Experimental Research 28 (12), S. 1925 - 1930 (2004)

Sättler, M. B.; Merkler, D.; Maier, K.; Stadelmann, C.; Ehrenreich, H.; Bähr, M.; Diem, R.: Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis. Cell Death and Differentiation 11 (Suppl. 2), S. S181 - S192 (2004)

Wagner, T.; Krampe, H.; Stawicki, S.; Reinhold, J.; Jahn, H.; Mahlke, K.; Barth, U.; Sieg, S.; Maul, O.; Galwas, C. et al.; Aust, C.; Kröner-Herwig, B.; Brunner, E.; Poser, W.; Henn, F.; Rüther, E.; Ehrenreich, H.: Substantial decrease of psychiatric comorbidity in chronic alcoholics upon integrated outpatient treatment - results of a prospective study. Journal of Psychiatric Research 38 (6), S. 619 - 635 (2004)

Ehrenreich, H.; Timner, W.; Siren, A.-L.: A novel role for an established player: anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemia. Transfusion and Apheresis Science 31 (1), S. 39 - 44 (2004)

Ehrenreich, H.: A boost for translational neuroscience. Science 305 (5681), S. 184 - 185 (2004)